Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Cancer Vaccines01:30

Cancer Vaccines

952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.4K
Overview
83.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red blood cell mediated drug delivery: Loading, release and clinical progress.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Co-Delivery of Ferrostatin-1 and M2 Macrophage-Derived Exosomal Signals via Engineered Hybrid Nanovesicles Enables Synergistic Neuroprotection in Traumatic Brain Injury.

ACS applied materials & interfaces·2026
Same author

Honeysuckle-derived vesicle-like nanoparticle and their hybrid vesicle as novel drug delivery systems for glioma therapy.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Injectable self-healing hydrogel loaded with a self-assembling LL-37 derivative for treating infected skin wounds.

International journal of pharmaceutics·2026
Same author

Targeted Reprogramming of Tumor Cells by Digoxin-Loaded Immunogenic Nanoparticles Enhances Immunity Against Disseminated Tumor Cells.

Advanced healthcare materials·2025
Same author

A Novel Gelatinase-Responsive Self-Assembled Antimicrobial Peptide for Combating Drug-Resistant Bacterial Infection.

ACS applied materials & interfaces·2025

Related Experiment Video

Updated: Jan 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Nanocarrier-based immunotherapy for viral diseases.

Dan Liu1,2, Te Zhao1,2, Yi Li2,3

  • 1School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.

International Journal of Pharmaceutics: X
|October 23, 2025
PubMed
Summary

Novel nanocarrier technology enhances immunotherapy for viral diseases, improving stability and targeting to overcome limitations and boost therapeutic efficacy against global health threats.

Keywords:
Immune checkpoint inhibitorsImmunotherapyNanocarriersT-cell immunotherapyVaccineViral diseases

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.7K

Area of Science:

  • Virology
  • Immunology
  • Nanotechnology

Background:

  • Viral diseases present significant global public health and economic challenges.
  • Current immunotherapy for viral infections faces limitations like poor stability, targeting, and toxicity.
  • Nanocarriers offer solutions by protecting therapeutics, enabling targeted delivery, and controlling release.

Purpose of the Study:

  • To review the classification and application of immunotherapy in viral diseases.
  • To explore the combination of immunotherapy with nanocarriers for enhanced viral disease treatment.
  • To discuss challenges and future prospects of nanocarrier-based immunotherapy.

Main Methods:

  • Literature review on immunotherapy and nanocarrier applications in virology.
  • Analysis of nanocarrier features relevant to overcoming immunotherapy limitations.
  • Synthesis of current research on combined immunotherapy and nanocarrier strategies.

Main Results:

  • Nanocarriers protect therapeutic agents from degradation and enable targeted delivery.
  • Controlled release from nanocarriers maintains optimal therapeutic concentrations.
  • Combining immunotherapy with nanocarriers shows potential to significantly improve treatment efficacy.

Conclusions:

  • Nanocarrier-mediated immunotherapy is a promising strategy to address limitations of traditional immunotherapy for viral infections.
  • This approach holds potential for improved prophylactic and therapeutic interventions against viral diseases.
  • Further research is needed to overcome challenges and fully realize the clinical prospects.